The Rs 613-crore IPO received bids for 12,34,860 shares against the total issue size of 1,71,66,309 shares, data available with NSE till 1700 hours showed.
The portion set aside for qualified institutional buyers (QIBs) and non-institutional investors was subscribed 10 per cent each.
The retail investor category saw a subscription of 13 per cent, according to BSE data.
Narayana Hrudayalaya has raised Rs 184 crore from 15 anchor investors, including the Singapore government, at the upper price band.
Post-IPO, promoters will have 65 per cent stake in the company.
The IPO includes an offer of sale of up to 2.45 crore equity shares from promoters and other existing shareholders, representing 14.04 per cent stake in the company.
The book running lead managers to the offer are Axis Capital, IDFC Securities and Jefferies India.
Narayana Hrudayalaya is the third company from the healthcare sector to launch IPO this month after diagnostic chain Dr Lal PathLabs and pharmaceutical firm Alkem Laboratories.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
